The rapid targeting and high tumor-background contrast of PSMA-Cy5 demonstrated that PSMA ligand-mediated prostate cancer targeted fluorescence imaging has high potential value, with important significance and value in basic scientific research and intraoperative navigation in clinical surgery. The gene discussed is FOLH1; the disease is neoplasm.